dihexa peptide price sciences dihexa peptide dosage PeptideLabz Copper Peptide 10% GHK-CU 5% AHK-CU Peptides Hair Growth Treatment Serum, Blue • » Dihexa (PNB-0408) | c-Met/HGFR Activator

Liquid formulations almost always require constant refrigeration and have shorter beyond-use dates

Phase 2 and Phase 3 trial data Major clinical trials: Phase 2 (24-week trial, 2008): 203 obese participants Three dose groups: 0.25mg, 0.5mg, 1.0mg daily Placebo-controlled, randomized Primary outcome: Weight loss percentage Phase 2 results: Key findings: Dose-dependent weight loss 1mg dose: Average 23 lbs lost (starting weight ~220 lbs) Best responders: 15-20% weight loss Comparable to semaglutide 2.4mg But higher dropout due to side effects Phase 3 trials (planned but never completed): Intended for FDA approval Halted due to cardiovascular concerns Increased heart rate 5-10 bpm average Blood pressure elevation 2-5 mmHg Risk-benefit ratio questioned Development suspended 2010 Long-term data (limited): 1-year extension studies showed sustained loss Weight plateau at 6-9 months Some regain if discontinued No controlled trials beyond 1 year Safety concerns prevented longer studies Compare to semaglutide trials and tirzepatide results

[DOI] [PMC free article] [PubMed] [Google Scholar] 48.Loewen S.M., Chavesa A.M., Murray C.J., Traetta M.E., Burns S.E., Pekarik K.H., Tremblay M.E

The honest answer is: we dont know